Gastric cancer, a significant global health challenge, is characterized by a complex transition from inflammation-induced premalignant lesions to malignancy.
Cancer Biology & Medicine Aug 8 2024 The quest for early diagnosis and prevention is impeded by the intricate biological shifts that mark this journey, highlighting an urgent need for a deeper dive into the underlying the multi-level and dynamic features.
From the Institute for TCM-X at Tsinghua University, a team of scientists has unveiled a pivotal review in the field of gastric cancer research. Published on August 17, 2023, in Cancer Biology & Medicine, the study employs AI and multi-omics to map the trajectory of gastric cancer development, offering an in-depth and holistic perspective on the disease's evolution.
This study meticulously dissects the complex interplay of biological factors in the onset of gastric cancer from inflammation. By fusing multimodal and multi-omics data with sophisticated AI, the researchers have identified a plethora of crucial biomarkers and potential intervention targets. The integration of single-cell transcriptomics offers detailed cellular insights, while network-based algorithms unveil the intricate molecular interconnections.
Our integrative methodology profoundly advances our comprehension of gastric cancer, pioneering the way for early detection biomarkers and targeted treatment strategies that are essential for advancing cancer care.
Gastric Cancer Inflammation Tumorigenesis Global Health Medicine Research
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Docosahexaenoic acid found to suppress gastric fundus smooth muscle contractions by inhibiting the Orai1 channelA research group led by Dr. Keisuke Obara, Dr.
Read more »
New prognostic marker identified for gastric cancer recurrence riskSurgical removal of the tumor is considered the basis for curing gastric cancer. However, 40 per cent of patients who have undergone surgery suffer a relapse within two years.
Read more »
Gastric cancer: Biomarkers identified to predict the risk of relapseSurgical removal of the tumor is considered the basis for curing gastric cancer. However, 40% of patients who have undergone surgery suffer a relapse within two years. A research team led by MedUni Vienna has now investigated a prognostic marker that can be used to identify patients with a high risk of tumor recurrence.
Read more »
Deciphering inflammation-induced tumorigenesis: Unveiling gastric cancer's trail with network and AIIn a pioneering venture, researchers have harnessed AI and multi-omics to shed light on the intricate pathways of gastric inflammation-induced tumorigenesis.
Read more »
Generation X, millennials in US have higher risk of developing 17 cancers compared to older generationsA new large study led by researchers at the American Cancer Society (ACS) suggests that incidence rates have continued to rise in successively younger generations in 17 of the 34 cancer types, including breast, pancreatic, and gastric cancers.
Read more »
Study shows growing cancer burden in younger generationsA new large study led by researchers at the American Cancer Society (ACS) suggests incidence rates continued to rise in successively younger generations in 17 of the 34 cancer types, including breast, pancreatic, and gastric cancers.
Read more »